Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
29
Number of overlapping holdings
47.5%
% of XLV's 61 holdings also in BMED
26.9%
% of BMED's 119 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus BMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in BMED |
Overlap | |
|---|---|---|---|---|
 |
INTUITIVE SURGICAL INC | 3.8% | 5.1% | 3.8% |
|
BOSTON SCIENTIFIC CORP | 2.7% | 4.8% | 2.7% |
|
ABBOTT LABORATORIES | 3.8% | 2.3% | 2.3% |
|
GILEAD SCIENCES INC | 2.2% | 3.1% | 2.2% |
|
DANAHER CORP | 3.0% | 1.8% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to BMED
|
ELI LILLY & CO | 12.3% |
|
UNITEDHEALTH GROUP INC | 9.4% |
|
JOHNSON & JOHNSON | 6.7% |
|
MERCK & CO. INC. | 4.9% |
|
ABBVIE INC | 4.3% |
|
THERMO FISHER SCIENTIFIC INC | 2.6% |
|
PFIZER INC | 2.2% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
|
ELEVANCE HEALTH INC | 1.7% |
|
AMGEN INC | 1.7% |
XLV Underweight Relative to BMED
 |
ARGENX SE ADR | -3.6% |
 |
ROCHE HOLDING AG-BR | -2.8% |
|
LONZA GROUP AG-REG | -2.6% |
|
UCB SA | -2.5% |
|
SAREPTA THERAPEUTICS INC | -2.1% |
|
BOSTON SCIENTIFIC CORP | -2.0% |
|
REPLIGEN CORP | -2.0% |
|
NEUROCRINE BIOSCIENCES INC | -1.9% |
|
BIO-TECHNE CORPORATION | -1.8% |
|
NATERA INC | -1.8% |